Peter Ochodnický

1.3k total citations
30 papers, 953 citations indexed

About

Peter Ochodnický is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Urology. According to data from OpenAlex, Peter Ochodnický has authored 30 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 10 papers in Physiology and 9 papers in Urology. Recurrent topics in Peter Ochodnický's work include Urinary Bladder and Prostate Research (9 papers), Nitric Oxide and Endothelin Effects (8 papers) and Renin-Angiotensin System Studies (8 papers). Peter Ochodnický is often cited by papers focused on Urinary Bladder and Prostate Research (9 papers), Nitric Oxide and Endothelin Effects (8 papers) and Renin-Angiotensin System Studies (8 papers). Peter Ochodnický collaborates with scholars based in Netherlands, Slovakia and United States. Peter Ochodnický's co-authors include Martin C. Michel, Robert H. Henning, Célia Duarte Cruz, Naoki Yoshimura, Dick de Zeeuw, Richard P.E. van Dokkum, Ján Klimas, Peter Křenek, Francisco Cruz and Ján Kyselovič and has published in prestigious journals such as Scientific Reports, The FASEB Journal and European Heart Journal.

In The Last Decade

Peter Ochodnický

30 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ochodnický Netherlands 18 285 261 187 138 134 30 953
Inés Stella Argentina 18 85 0.3× 263 1.0× 363 1.9× 233 1.7× 245 1.8× 31 1.2k
Fabiano Beraldi Calmasini Brazil 17 248 0.9× 70 0.3× 129 0.7× 170 1.2× 112 0.8× 49 660
Figen Gürdöl Türkiye 21 19 0.1× 110 0.4× 156 0.8× 128 0.9× 208 1.6× 61 966
Yu‐Shien Ko Taiwan 19 19 0.1× 383 1.5× 747 4.0× 82 0.6× 147 1.1× 40 1.5k
Gwo‐Jyh Chang Taiwan 20 31 0.1× 449 1.7× 409 2.2× 79 0.6× 85 0.6× 68 1.2k
Theodora Szasz United States 15 31 0.1× 361 1.4× 212 1.1× 95 0.7× 236 1.8× 28 861
Sun‐Yran Chang Taiwan 18 184 0.6× 27 0.1× 388 2.1× 45 0.3× 65 0.5× 82 1.2k
Hisao Wakasaki Japan 16 20 0.1× 593 2.3× 740 4.0× 250 1.8× 246 1.8× 34 1.6k
Nasser A. Dhayat Switzerland 17 18 0.1× 407 1.6× 425 2.3× 209 1.5× 105 0.8× 43 1.2k
J.Y. Jeremy United Kingdom 14 27 0.1× 158 0.6× 120 0.6× 68 0.5× 187 1.4× 31 715

Countries citing papers authored by Peter Ochodnický

Since Specialization
Citations

This map shows the geographic impact of Peter Ochodnický's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ochodnický with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ochodnický more than expected).

Fields of papers citing papers by Peter Ochodnický

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ochodnický. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ochodnický. The network helps show where Peter Ochodnický may publish in the future.

Co-authorship network of co-authors of Peter Ochodnický

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ochodnický. A scholar is included among the top collaborators of Peter Ochodnický based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ochodnický. Peter Ochodnický is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochodnický, Peter, Lotte Kors, Elena Rampanelli, et al.. (2019). β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effect. Scientific Reports. 9(1). 17633–17633. 11 indexed citations
2.
Rampanelli, Elena, Evelyn Orsó, Peter Ochodnický, et al.. (2017). Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation. Scientific Reports. 7(1). 2861–2861. 35 indexed citations
3.
Ochodnický, Peter, Jesper Kers, Nike Claessen, et al.. (2017). Increased Circulating and Urinary Levels of Soluble TAM Receptors in Diabetic Nephropathy. American Journal Of Pathology. 187(9). 1971–1983. 18 indexed citations
4.
Ochodnický, Peter, Nike Claessen, Jaklien C. Leemans, et al.. (2016). Renal endothelial protein C receptor expression and shedding during diabetic nephropathy. Journal of Thrombosis and Haemostasis. 14(6). 1171–1182. 23 indexed citations
5.
Klimas, Ján, et al.. (2015). Daunorubicine-induced downregulation of cardiac PPARs expression was prevented by ramipril. European Heart Journal. 36. 149–150. 1 indexed citations
6.
Ochodnický, Peter, Ján Klimas, Peter Křenek, et al.. (2014). Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat. European Journal of Pharmacology. 730. 51–60. 17 indexed citations
7.
Ochodnický, Peter, et al.. (2013). Bradykinin modulates spontaneous nerve growth factor production and stretch-induced ATP release in human urothelium. Pharmacological Research. 70(1). 147–154. 27 indexed citations
8.
Kučerová, Dana, Jana Kmecova, Ján Kyselovič, et al.. (2013). Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy. European Journal of Pharmacology. 714(1-3). 472–477. 19 indexed citations
9.
Ochodnický, Peter, et al.. (2012). Expression profiling of G‐protein‐coupled receptors in human urothelium and related cell lines. British Journal of Urology. 110(6b). E293–300. 31 indexed citations
10.
Ochodnický, Peter, Célia Duarte Cruz, Naoki Yoshimura, & Francisco Cruz. (2012). Neurotrophins as regulators of urinary bladder function. Nature Reviews Urology. 9(11). 628–637. 82 indexed citations
11.
Ochodnický, Peter, Célia Duarte Cruz, Naoki Yoshimura, & Martin C. Michel. (2011). Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target. Neurourology and Urodynamics. 30(7). 1227–1241. 107 indexed citations
12.
Michel, Martin C., Peter Ochodnický, Yukio Homma, & Yasuhiko Igawa. (2011). β-Adrenoceptor agonist effects in experimental models of bladder dysfunction. Pharmacology & Therapeutics. 131(1). 40–49. 28 indexed citations
13.
Michel, Martin C., et al.. (2011). Desirable properties of β3-adrenoceptor agonists: Implications for the selection of drug development candidates. European Journal of Pharmacology. 657(1-3). 1–3. 9 indexed citations
14.
Křenek, Peter, Jana Kmecova, Dana Kučerová, et al.. (2009). Isoproterenol-Induced Heart Failure in the Rat is Associated with Nitric Oxide-Dependent Functional Alterations of Cardiac Function. European Journal of Heart Failure. 11(2). 140–146. 98 indexed citations
15.
Ochodnický, Peter, Robert H. Henning, Hendrik Buikema, et al.. (2009). Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat. American Journal of Physiology-Renal Physiology. 298(3). F625–F633. 30 indexed citations
16.
Klimas, Ján, Jana Kmecova, Zuzana Kyseľová, et al.. (2009). Pycnogenol® improves left ventricular function in streptozotocin‐induced diabetic cardiomyopathy in rats. Phytotherapy Research. 24(7). 969–974. 15 indexed citations
17.
Ochodnický, Peter, et al.. (2008). Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage. Nephrology Dialysis Transplantation. 24(2). 413–420. 10 indexed citations
18.
Ochodnický, Peter, et al.. (2006). The role of angiotensin(1–7) in renal vasculature of the rat. Journal of Hypertension. 24(10). 1971–1978. 39 indexed citations
19.
Ochodnický, Peter, et al.. (2006). Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response. Journal of Nephrology. 19(3). 246–258. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inés Stella Breakdown of academic impact, for papers by Fabiano Beraldi Calmasini Breakdown of academic impact, for papers by Figen Gürdöl Breakdown of academic impact, for papers by Yu‐Shien Ko Breakdown of academic impact, for papers by Gwo‐Jyh Chang Breakdown of academic impact, for papers by Theodora Szasz Breakdown of academic impact, for papers by Sun‐Yran Chang Breakdown of academic impact, for papers by Hisao Wakasaki Breakdown of academic impact, for papers by Nasser A. Dhayat Breakdown of academic impact, for papers by J.Y. Jeremy
Rankless by CCL
2026